A nervous predisposition to unrepaired DNA double strand breaks

DNA Repair

Volumn 12, Issue 8, 2013, Pages 588-599

  Reynolds, John J ^a   Stewart, Grant S ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; DOUBLE STRANDED DNA; MRE11 PROTEIN;

ATAXIA TELANGIECTASIA; ATAXIA TELANGIECTASIA LIKE DISORDER; CEREBELLUM DEGENERATION; DNA END JOINING REPAIR; DNA REPAIR; DNA STRAND BREAKAGE; GENE MUTATION; HETEROZYGOSITY; HOMOLOGOUS RECOMBINATION; HUMAN; NERVE DEGENERATION; NIJMEGEN BREAKAGE SYNDROME; NIJMEGEN BREAKAGE SYNDROME LIKE DISORDER; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW;

ATAXIA TELANGIECTASIA; ATAXIA TELANGIECTASIA MUTATED PROTEINS; DNA BREAKS, DOUBLE-STRANDED; DNA REPAIR; DNA REPAIR-DEFICIENCY DISORDERS; GENETIC PREDISPOSITION TO DISEASE; GROWTH DISORDERS; HUMANS; MICROCEPHALY; MUTATION; NERVOUS SYSTEM; NEURODEGENERATIVE DISEASES; NEURONS; NIJMEGEN BREAKAGE SYNDROME; RADIATION, IONIZING;

ATAXIA TELANGIECTASIA;

EID: 84880594523     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2013.04.011     Document Type: Review

References (137)

1. Taylor A.M., Harnden D.G., Arlett C.F., Harcourt S.A., Lehmann A.R., Stevens S., Bridges B.A. Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature 1975, 258(5534):427-429.
2. Domínguez-Gerpe L., Araújo-Vilar D. Prematurely aged children: molecular alterations leading to Hutchinson-Gilford progeria and Werner syndromes. Curr. Aging. Sci. 2008, 1(3):202-212.
3. Boboila C., Jankovic M., Yan C.T., Wang J.H., Wesemann D.R., Zhang T., Fazeli A., Feldman L., Nussenzweig A., Nussenzweig M., Alt F.W. Alternative end-joining catalyzes robust IgH locus deletions and translocations in the combined absence of ligase 4 and Ku70. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:3034-3039.
4. Simsek D., Jasin M. Alternative end-joining is suppressed by the canonical NHEJ component Xrcc4-ligase IV during chromosomal translocation formation. Nat. Struct. Mol. Biol. 2010, 17:410-416.
5. Hiom K. Coping with DNA double strand breaks. DNA Repair (Amst) 2010, 9:1256-1263.
6. Holthausen J.T., Wyman C., Kanaar R. Regulation of DNA strand exchange in homologous recombination. DNA Repair (Amst) 2010, 9:1264-1272.
7. Lieber M.R. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu. Rev. Biochem. 2010, 79:181-211.
8. Löbrich M., Shibata A., Beucher A., Fisher A., Ensminger M., Goodarzi A.A., Barton O., Jeggo P.A. gammaH2AX foci analysis for monitoring DNA double-strand break repair: strengths, limitations and optimization. Cell Cycle 2010, 9(4):662-669.
9. Jeggo P.A., Geuting V., Löbrich M. The role of homologous recombination in radiation-induced double-strand break repair. Radiother. Oncol. 2011, 101:7-12.
10. Shibata A., Conrad S., Birraux J., Geuting V., Barton O., Ismail A., Kakarougkas A., Meek K., Taucher-Scholz G., Löbrich M., Jeggo P.A. Factors determining DNA double-strand break repair pathway choice in G2 phase. EMBO J. 2011, 30:1079-1092.
11. Symington L.S., Gautier J. Double-strand break end resection and repair pathway choice. Annu. Rev. Genet. 2011, 45:247-271.
12. Sartori A.A., Lukas C., Coates J., Mistrik M., Fu S., Bartek J., Baer R., Lukas J., Jackson S.P. Human CtIP promotes DNA end resection. Nature 2007, 450:509-514.
13. Gravel S., Chapman J.R., Magill C., Jackson S.P. DNA helicases Sgs1 and BLM promote DNA double-strand break resection. Genes Dev. 2008, 22:2767-2772.
14. Huertas P., Jackson S.P. Human CtIP mediates cell cycle control of DNA end resection and double strand break repair. J. Biol. Chem. 2009, 284:9558-9565.
15. You Z., Shi L.Z., Zhu Q., Wu P., Zhang Y.W., Basilio A., Tonnu N., Verma I.M., Berns M.W., Hunter T. CtIP links DNA double-strand break sensing to resection. Mol. Cell. 2009, 36:954-969.
16. Nimonkar A.V., Genschel J., Kinoshita E., Polaczek P., Campbell J.L., Wyman C., Modrich P., Kowalczykowski S.C. BLM-DNA2-RPA-MRN and EXO1-BLM-RPA-MRN constitute two DNA end resection machineries for human DNA break repair. Genes Dev. 2011, 25:350-362.
17. Chen X., Niu H., Chung W.H., Zhu Z., Papusha A., Shim E.Y., Lee S.E., Sung P., Ira G. Cell cycle regulation of DNA double-strand break end resection by Cdk1-dependent Dna2 phosphorylation. Nat. Struct. Mol. Biol. 2011, 18:1015-1019.
18. Buis J., Stoneham T., Spehalski E., Ferguson D.O. Mre11 regulates CtIP-dependent double-strand break repair by interaction with CDK2. Nat. Struct. Mol. Biol. 2012, 19:246-252.
19. Falck J., Forment J.V., Coates J., Mistrik M., Lukas J., Bartek J., Jackson S.P. CDK targeting of NBS1 promotes DNA-end resection, replication restart and homologous recombination. EMBO Rep. 2012, (Epub ahead of print). 10.1038/embor.2012.58.
20. Difilippantonio S., Gapud E., Wong N., Huang C.Y., Mahowald G., Chen H.T., Kruhlak M.J., Callen E., Livak F., Nussenzweig M.C., Sleckman B.P., Nussenzweig A. 53BP1 facilitates long-range DNA end-joining during V(D)J recombination. Nature 2008, 456:529-533.
21. Bunting S.F., Callén E., Wong N., Chen H.T., Polato F., Gunn A., Bothmer A., Feldhahn N., Fernandez-Capetillo O., Cao L., Xu X., Deng C.X., Finkel T., Nussenzweig M., Stark J.M., Nussenzweig A. 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks. Cell 2010, 141:243-254.
22. Bothmer A., Robbiani D.F., Di Virgilio M., Bunting S.F., Klein I.A., Feldhahn N., Barlow J., Chen H.T., Bosque D., Callen E., Nussenzweig A., Nussenzweig M.C. Regulation of DNA end joining, resection, and immunoglobulin class switch recombination by 53BP1. Mol. Cell. 2011, 42:319-329.
23. Costanzo V. Brca2, Rad51 and Mre11: performing balancing acts on replication forks. DNA Repair (Amst) 2011, 10:1060-1065.
24. Bryant H.E., Petermann E., Schultz N., Jemth A.S., Loseva O., Issaeva N., Johansson F., Fernandez S., McGlynn P., Helleday T. PARP is activated at stalled forks to mediate Mre11-dependent replication restart and recombination. EMBO J. 2009, 28:2601-2615.
25. Schlacher K., Christ N., Siaud N., Egashira A., Wu H., Jasin M. Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11. Cell 2011, 145:529-542.
26. Petermann E., Helleday T. Pathways of mammalian replication fork restart. Nat. Rev. Mol. Cell. Biol. 2010, 11(10):683-687.
27. Boder E. Ataxia-telangiectasia: an overview. Kroc Found. Ser. 1985, 19:1-63.
28. Gilad S., Chessa L., Khosravi R., Russell P., Galanty Y., Piane M., Gatti R.A., Jorgensen T.J., Shiloh Y., Bar-Shira A. Genotype-phenotype relationships in ataxia-telangiectasia and variants. Am. J. Hum. Genet. 1998, 62:551-561.
29. Stankovic T., Kidd A.M., Sutcliffe A., McGuire G.M., Robinson P., Weber P., Bedenham T., Bradwell A.R., Easton D.F., Lennox G.G., Haites N., Byrd P.J., Taylor A.M. ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am. J. Hum. Genet. 1998, 62:334-345.
30. Becker-Catania S.G., Chen G., Hwang M.J., Wang Z., Sun X., Sanal O., Bernatowska-Matuszkiewicz E., Chessa L., Lee E.Y., Gatti R.A. Ataxia-telangiectasia: phenotype/genotype studies of ATM protein expression, mutations, and radiosensitivity. Mol. Genet. Metab. 2000, 70:122-133.
31. Demuth I., Dutrannoy V., Marques W., Neitzel H., Schindler D., Dimova P.S., Chrzanowska K.H., Bojinova V., Gregorek H., Graul-Neumann L.M., von Moers A., Schulze I., Nicke M., Bora E., Cankaya T., Oláh É., Kiss C., Bessenyei B., Szakszon K., Gruber-Sedlmayr U., Kroisel P.M., Sodia S., Goecke T.O., Dörk T., Digweed M., Sperling K., de Sá J., Lourenco C.M., Varon R. New mutations in the ATM gene and clinical data of 25 AT patients. Neurogenetics 2011, 12:273-282.
32. Verhagen M.M., Last J.I., Hogervorst F.B., Smeets D.F., Roeleveld N., Verheijen F., Catsman-Berrevoets C.E., Wulffraat N.M., Cobben J.M., Hiel J., Brunt E.R., Peeters E.A., Gómez Garcia E.B., van der Knaap M.S., Lincke C.R., Laan L.A., Tijssen M.A., van Rijn M.A., Majoor-Krakauer D., Visser M., van't Veer L.J., Kleijer W.J., van de Warrenburg B.P., Warris A., de Groot I.J., de Groot R., Broeks A., Preijers F., Kremer B.H., Weemaes C.M., Taylor M.A., van Deuren M., Willemsen M.A. Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia-telangiectasia: a genotype-phenotype study. Hum. Mutat. 2012, 33:561-571.
33. Verhagen M.M., Martin J.J., van Deuren M., Ceuterick-de Groote C., Weemaes C.M., Kremer B.H., Taylor M.A., Willemsen M.A., Lammens M. Neuropathology in classical and variant ataxia-telangiectasia. Neuropathology 2012, 32:234-244.
34. Crawford T.O., Mandir A.S., Lefton-Greif M.A., Goodman S.N., Goodman B.K., Sengul H., Lederman H.M. Quantitative neurologic assessment of ataxia-telangiectasia. Neurology 2000, 54:1505-1509.
35. Elson A., Wang Y., Daugherty C.J., Morton C.C., Zhou F., Campos-Torres J., Leder P. Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:13084-13089.
36. Xu Y., Ashley T., Brainerd E.E., Bronson R.T., Meyn M.S., Baltimore D. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev. 1996, 10:2411-2422.
37. Kuljis R.O., Xu Y., Aguila M.C., Baltimore D. Degeneration of neurons, synapses, and neuropil and glial activation in a murine Atm knockout model of ataxia-telangiectasia. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:12688-12693.
38. Herzog K.H., Chong M.J., Kapsetaki M., Morgan J.I., McKinnon P.J. Requirement for Atm in ionizing radiation-induced cell death in the developing central nervous system. Science 1998, 280:1089-1091.
39. Savitsky K., Bar-Shira A., Gilad S., Rotman G., Ziv Y., Vanagaite L., Tagle D.A., Smith S., Uziel T., Sfez S., Ashkenazi M., Pecker I., Frydman M., Harnik R., Patanjali S.R., Simmons A., Clines G.A., Sartiel A., Gatti R.A., Chessa L., Sanal O., Lavin M.F., Jaspers N.G., Taylor A.M., Arlett C.F., Miki T., Weissman S.M., Lovett M., Collins F.S., Shiloh Y. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995, 268:1749-1753.
40. Bakkenist C.J., Kastan M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003, 421:499-506.
41. Kozlov S.V., Graham M.E., Jakob B., Tobias F., Kijas A.W., Tanuji M., Chen P., Robinson P.J., Taucher-Scholz G., Suzuki K., So S., Chen D., Lavin M.F. Autophosphorylation and ATM activation: additional sites add to the complexity. J. Biol. Chem. 2011, 286(11):9107-9119.
42. Alterman N., Fattal-Valevski A., Moyal L., Crawford T.O., Lederman H.M., Ziv Y., Shiloh Y. Ataxia-telangiectasia: mild neurological presentation despite null ATM mutation and severe cellular phenotype. Am. J. Med. Genet. A 2007, 143A:1827-1834.
43. McConville C.M., Stankovic T., Byrd P.J., McGuire G.M., Yao Q.Y., Lennox G.G., Taylor M.R. Mutations associated with variant phenotypes in ataxia-telangiectasia. Am. J. Hum. Genet. 1996, 59:320-330.
44. Sutton I.J., Last J.I., Ritchie S.J., Harrington H.J., Byrd P.J., Taylor A.M. Adult-onset ataxia telangiectasia due to ATM 5762ins137 mutation homozygosity. Ann. Neurol. 2004, 55:891-895.
45. Verhagen M.M., Abdo W.F., Willemsen M.A., Hogervorst F.B., Smeets D.F., Hiel J.A., Brunt E.R., van Rijn M.A., Majoor Krakauer D., Oldenburg R.A., Broeks A., Last J.I., van't Veer L.J., Tijssen M.A., Dubois A.M., Kremer H.P., Weemaes C.M., Taylor A.M., van Deuren M. Clinical spectrum of ataxia-telangiectasia in adulthood. Neurology 2009, 73:430-437.
46. Byrd P.J., Srinivasan V., Last J.I., Smith A., Biggs P., Carney E.F., Exley A., Abson C., Stewart G.S., Izatt L., Taylor A.M. Severe reaction to radiotherapy for breast cancer as the presenting feature of ataxia telangiectasia. Br. J. Cancer 2012, 106:262-268.
47. Derheimer F.A., Kastan M.B. Multiple roles of ATM in monitoring and maintaining DNA integrity. FEBS Lett. 2010, 584:3675-3681.
48. Bensimon A., Aebersold R., Shiloh Y. Beyond ATM: the protein kinase landscape of the DNA damage response. FEBS Lett. 2011, 585:1625-1639.
49. Ditch S., Paull T.T. The ATM protein kinase and cellular redox signaling: beyond the DNA damage response. Trends Biochem. Sci. 2012, 37:15-22.
50. Lavin M.F. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat. Rev. Mol. Cell Biol. 2008, 9:759-769.
51. Foray N., Priestley A., Alsbeih G., Badie C., Capulas E.P., Arlett C.F., Malaise E.P. Hypersensitivity of ataxia telangiectasia fibroblasts to ionizing radiation is associated with a repair deficiency of DNA double-strand breaks. Int. J. Radiat. Biol. 1997, 72(3):271-283.
52. Löbrich M., Kühne M., Wetzel J., Rothkamm K. Joining of correct and incorrect DNA double-strand break ends in normal human and ataxia telangiectasia fibroblasts. Genes Chromosomes Cancer 2000, 27:59-68.
53. Kühne M., Riballo E., Rief N., Rothkamm K., Jeggo P.A., Löbrich M. A double-strand break repair defect in ATM-deficient cells contributes to radiosensitivity. Cancer Res. 2004, 64:500-508.
54. Riballo E., Kühne M., Rief N., Doherty A., Smith G.C., Recio M.J., Reis C., Dahm K., Fricke A., Krempler A., Parker A.R., Jackson S.P., Gennery A., Jeggo P.A., Löbrich M. A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to gamma-H2AX foci. Mol. Cell. 2004, 16:715-724.
55. Beucher A., Birraux J., Tchouandong L., Barton O., Shibata A., Conrad S., Goodarzi A.A., Krempler A., Jeggo P.A., Löbrich M.A.T.M Artemis promote homologous recombination of radiation-induced DNA double-strand breaks in G2. EMBO J. 2009, 28:3413-3427.
56. Morrison C., Sonoda E., Takao N., Shinohara A., Yamamoto K., Takeda S. The controlling role of ATM in homologous recombinational repair of DNA damage. EMBO J. 2000, 19:463-471.
57. Goodarzi A.A., Noon A.T., Deckbar D., Ziv Y., Shiloh Y., Löbrich M., Jeggo P.A. ATM signaling facilitates repair of DNA double-strand breaks associated with heterochromatin. Mol. Cell. 2008, 31:167-177.
58. Grewal S.I., Jia S. Heterochromatin revisited. Nat. Rev. Genet. 2007, 8:35-46.
59. Ziv Y., Bielopolski D., Galanty Y., Lukas C., Taya Y., Schultz D.C., Lukas J., Bekker-Jensen S., Bartek J., Shiloh Y. Chromatin relaxation in response to DNA double-strand breaks is modulated by a novel ATM- and KAP-1 dependent pathway. Nat. Cell Biol. 2006, 8:870-876.
60. Goodarzi A.A., Jeggo P., Lobrich M. The influence of heterochromatin on DNA double strand break repair: G getting the strong, silent type to relax. DNA Repair (Amst) 2010, 9:1273-1282.
61. Noon A.T., Shibata A., Rief N., Löbrich M., Stewart G.S., Jeggo P.A., Goodarzi A.A. 53BP1-dependent robust localized KAP-1 phosphorylation is essential for heterochromatic DNA double-strand break repair. Nat. Cell Biol. 2010, 12:177-184.
62. Goodarzi A.A., Kurka T., Jeggo P.A. KAP-1 phosphorylation regulates CHD3 nucleosome remodeling during the DNA double-strand break response. Nat. Struct. Mol. Biol. 2011, 18:831-839.
63. Kriaucionis S., Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 2009, 324:929-930.
64. Yang Y., Herrup K. Loss of neuronal cell cycle control in ataxia-telangiectasia: a unified disease mechanism. J. Neurosci. 2005, 25:2522-2529.
65. Busser J., Geldmacher D.S., Herrup K. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. J. Neurosci. 1998, 18:2801-2807.
66. Ranganathan S., Bowser R. Alterations in G(1) to S phase cell-cycle regulators during amyotrophic lateral sclerosis. Am. J. Pathol. 2003, 162:823-835.
67. Yang Y., Mufson E.J., Herrup K. Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer's disease. J. Neurosci. 2003, 23:2557-2563.
68. Li J., Chen J., Ricupero C.L., Hart R.P., Schwartz M.S., Kusnecov A., Herrup K. Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia. Nat. Med. 2012, (Epub ahead of print). 10.1038/nm.2709.
69. Chrzanowska K.H., Gregorek H., Dembowska-Bagińska B., Kalina M.A., Digweed M. Nijmegen breakage syndrome (NBS). Orphanet J. Rare Dis. 2012, 7:13.
70. Carney J.P., Maser R.S., Olivares H., Davis E.M., Le Beau M., Yates J.R., Hays L., Morgan W.F., Petrini J.H. The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell 1998, 93:477-486.
71. Matsuura S., Tauchi H., Nakamura A., Kondo N., Sakamoto S., Endo S., Smeets D., Solder B., Belohradsky B.H., Der Kaloustian V.M., Oshimura M., Isomura M., Nakamura Y., Komatsu K. Positional cloning of the gene for Nijmegen breakage syndrome. Nat. Genet. 1998, 19:179-181.
72. Varon R., Vissinga C., Platzer M., Cerosaletti K.M., Chrzanowska K.H., Saar K., Beckmann G., Seemanová E., Cooper P.R., Nowak N.J., Stumm M., Weemaes C.M., Gatti R.A., Wilson R.K., Digweed M., Rosenthal A., Sperling K., Concannon P., Reis A., Nibrin a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 1998, 93:467-476.
73. Zhu J., Petersen S., Tessarollo L., Nussenzweig A. Targeted disruption of the Nijmegen breakage syndrome gene NBS1 leads to early embryonic lethality in mice. Curr. Biol. 2001, 11:105-109.
74. Maser R.S., Zinkel R., Petrini J.H. An alternative mode of translation permits production of a variant NBS1 protein from the common Nijmegen breakage syndrome allele. Nat. Genet. 2001, 27:417-421.
75. Stracker T.H., Petrini J.H. The MRE11 complex: starting from the ends. Nat. Rev. Mol. Cell Biol. 2011, 12:90-103.
76. Horejsí Z., Falck J., Bakkenist C.J., Kastan M.B., Lukas J., Bartek J. Distinct functional domains of Nbs1 modulate the timing and magnitude of ATM activation after low doses of ionizing radiation. Oncogene 2004, 23:3122-3127.
77. Lloyd J., Chapman J.R., Clapperton J.A., Haire L.F., Hartsuiker E., Li J., Carr A.M., Jackson S.P., Smerdon S.J. A supramodular FHA/BRCT-repeat architecture mediates Nbs1 adaptor function in response to DNA damage. Cell 2009, 139:100-111.
78. Williams R.S., Dodson G.E., Limbo O., Yamada Y., Williams J.S., Guenther G., Classen S., Glover J.N., Iwasaki H., Russell P., Tainer J.A. Nbs1 flexibly tethers Ctp1 and Mre11-Rad50 to coordinate DNA double-strand break processing and repair. Cell 2009, 139:87-99.
79. Quennet V., Beucher A., Barton O., Takeda S., Löbrich M. CtIP and MRN promote non-homologous end-joining of etoposide-induced DNA double-strand breaks in G1. Nucleic Acids Res. 2011, 39:2144-2152.
80. Chapman J.R., Jackson S.P. Phospho-dependent interactions between NBS1 and MDC1 mediate chromatin retention of the MRN complex at sites of DNA damage. EMBO Rep. 2008, 9:795-801.
81. Melander F., Bekker-Jensen S., Falck J., Bartek J., Mailand N., Lukas J. Phosphorylation of SDT repeats in the MDC1 N terminus triggers retention of NBS1 at the DNA damage-modified chromatin. J. Cell Biol. 2008, 181:213-226.
82. Spycher C., Miller E.S., Townsend K., Pavic L., Morrice N.A., Janscak P., Stewart G.S., Stucki M. Constitutive phosphorylation of MDC1 physically links the MRE11-RAD50-NBS1 complex to damaged chromatin. J. Cell Biol. 2008, 181:227-240.
83. Wu L., Luo K., Lou Z., Chen J. MDC1 regulates intra-S-phase checkpoint by targeting NBS1 to DNA double-strand breaks. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:11200-11205.
84. Hari F.J., Spycher C., Jungmichel S., Pavic L., Stucki M. A divalent FHA/BRCT-binding mechanism couples the MRE11-RAD50-NBS1 complex to damaged chromatin. EMBO Rep. 2010, 11:387-392.
85. Difilippantonio S., Celeste A., Fernandez-Capetillo O., Chen H.T., Reina San Martin B., Van Laethem F., Yang Y.P., Petukhova G.V., Eckhaus M., Feigenbaum L., Manova K., Kruhlak M., Camerini-Otero R.D., Sharan S., Nussenzweig M., Nussenzweig A. Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models. Nat. Cell Biol. 2005, 7:675-685.
86. Børglum A.D., Balslev T., Haagerup A., Birkebaek N., Binderup H., Kruse T.A., Hertz J.M. A new locus for Seckel syndrome on chromosome 18p11.31-q11.2. Eur. J. Hum. Genet. 2001, 9:753-757.
87. Qvist P., Huertas P., Jimeno S., Nyegaard M., Hassan M.J., Jackson S.P., Børglum A.D. CtIP mutations cause seckel and jawad syndromes. PLoS Genet. 2011, 7:e1002310.
88. Hassan M.J., Chishti M.S., Jamal S.M., Tariq M., Ahmad W. A syndromic form of autosomal recessive congenital microcephaly (Jawad syndrome) maps to chromosome 18p11.22-q11.2. Hum. Genet. 2008, 123:77-82.
89. Falck J., Coates J., Jackson S.P. Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature 2005, 434:605-611.
90. Stracker T.H., Morales M., Couto S.S., Hussein H., Petrini J.H. The carboxy terminus of NBS1 is required for induction of apoptosis by the MRE11 complex. Nature 2007, 447:218-221.
91. Kang J., Bronson R.T., Xu Y. Targeted disruption of NBS1 reveals its roles in mouse development and DNA repair. EMBO J. 2002, 21:1447-1455.
92. Williams B.R., Mirzoeva O.K., Morgan W.F., Lin J., Dunnick W., Petrini J.H. A murine model of Nijmegen breakage syndrome. Curr. Biol. 2002, 12:648-653.
93. Frappart P.O., Tong W.M., Demuth I., Radovanovic I., Herceg Z., Aguzzi A., Digweed M., Wang Z.Q. An essential function for NBS1 in the prevention of ataxia and cerebellar defects. Nat. Med. 2005, 11:538-544.
94. Shull E.R., Lee Y., Nakane H., Stracker T.H., Zhao J., Russell H.R., Petrini J.H., McKinnon P.J. Differential DNA damage signaling accounts for distinct neural apoptotic responses in ATLD and NBS. Genes Dev. 2009, 23:171-180.
95. Seemanová E., Sperling K., Neitzel H., Varon R., Hadac J., Butova O., Schröck E., Seeman P., Digweed M. Nijmegen breakage syndrome (NBS) with neurological abnormalities and without chromosomal instability. J. Med. Genet. 2006, 43:218-224.
96. Warcoin M., Lespinasse J., Despouy G., Dubois d'Enghien C., Laugé A., Portnoï M.F., Christin-Maitre S., Stoppa-Lyonnet D., Stern M.H. Fertility defects revealing germline biallelic nonsense NBN mutations. Hum. Mutat. 2009, 30:424-430.
97. Curry C.J., O'Lague P., Tsai J., Hutchison H.T., Jaspers N.G., Wara D., Gatti R.A. ATFresno: a phenotype linking ataxia-telangiectasia with the Nijmegen breakage syndrome. Am. J. Hum. Genet. 1989, 45:270-275.
98. Stewart G.S., Maser R.S., Stankovic T., Bressan D.A., Kaplan M.I., Jaspers N.G., Raams A., Byrd P.J., Petrini J.H., Taylor A.M. The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell 1999, 99:577-587.
99. Delia D., Piane M., Buscemi G., Savio C., Palmeri S., Lulli P., Carlessi L., Fontanella E., Chessa L. MRE11 mutations and impaired ATM-dependent responses in an Italian family with ataxia-telangiectasia-like disorder. Hum. Mol. Genet. 2004, 13:2155-2163.
100. Fernet M., Gribaa M., Salih M.A., Seidahmed M.Z., Hall J., Koenig M. Identification and functional consequences of a novel MRE11 mutation affecting 10 Saudi Arabian patients with the ataxia telangiectasia-like disorder. Hum. Mol. Genet. 2005, 14:307-318.
101. Uchisaka N., Takahashi N., Sato M., Kikuchi A., Mochizuki S., Imai K., Nonoyama S., Ohara O., Watanabe F., Mizutani S., Hanada R., Morio T. Two brothers with ataxia-telangiectasia-like disorder with lung adenocarcinoma. J. Pediatr. 2009, 155:435-438.
102. Matsumoto Y., Miyamoto T., Sakamoto H., Izumi H., Nakazawa Y., Ogi T., Tahara H., Oku S., Hiramoto A., Shiiki T., Fujisawa Y., Ohashi H., Sakemi Y., Matsuura S. Two unrelated patients with MRE11A mutations and Nijmegen breakage syndrome-like severe microcephaly. DNA Repair (Amst) 2011, 10:314-321.
103. Hopfner K.P., Karcher A., Craig L., Woo T.T., Carney J.P., Tainer J.A. Structural biochemistry and interaction architecture of the DNA double-strand break repair Mre11 nuclease and Rad50-ATPase. Cell 2001, 105:473-485.
104. Williams R.S., Moncalian G., Williams J.S., Yamada Y., Limbo O., Shin D.S., Groocock L.M., Cahill D., Hitomi C., Guenther G., Moiani D., Carney J.P., Russell P., Tainer J.A. Mre11 dimers coordinate DNA end bridging and nuclease processing in double-strand-break repair. Cell 2008, 135:97-109.
105. Lammens K., Bemeleit D.J., Möckel C., Clausing E., Schele A., Hartung S., Schiller C.B., Lucas M., Angermüller C., Söding J., Strässer K., Hopfner K.P. The Mre11:Rad50 structure shows an ATP-dependent molecular clamp in DNA double-strand break repair. Cell 2011, 145:54-66.
106. Buis J., Wu Y., Deng Y., Leddon J., Westfield G., Eckersdorff M., Sekiguchi J.M., Chang S., Ferguson D.O. Mre11 nuclease activity has essential roles in DNA repair and genomic stability distinct from ATM activation. Cell 2008, 135:85-96.
107. Aravind L., Walker D.R., Koonin E.V. Conserved domains in DNA repair proteins and evolution of repair systems. Nucleic Acids Res. 1999, 27:1223-1242.
108. Pitts S.A., Kullar H.S., Stankovic T., Stewart G.S., Last J.I., Bedenham T., Armstrong S.J., Piane M., Chessa L., Taylor A.M. Byrd PJ. hMRE11: genomic structure and a null mutation identified in a transcript protected from nonsense-mediated mRNA decay. Hum. Mol. Genet. 2001, 10:1155-1162.
109. Waltes R., Kalb R., Gatei M., Kijas A.W., Stumm M., Sobeck A., Wieland B., Varon R., Lerenthal Y., Lavin M.F., Schindler D., Dörk T. Human RAD50 deficiency in a Nijmegen breakage syndrome-like disorder. Am. J. Hum. Genet. 2009, 84:605-616.
110. Luo G., Yao M.S., Bender C.F., Mills M., Bladl A.R., Bradley A., Petrini J.H. Disruption of mRad50 causes embryonic stem cell lethality, abnormal embryonic development, and sensitivity to ionizing radiation. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:7376-7381.
111. Hopfner K.P., Craig L., Moncalian G., Zinkel R.A., Usui T., Owen B.A., Karcher A., Henderson B., Bodmer J.L., McMurray C.T., Carney J.P., Petrini J.H., Tainer J.A. The Rad50 zinc-hook is a structure joining Mre11 complexes in DNA recombination and repair. Nature 2002, 418:562-566.
112. Williams G.J., Lees-Miller S.P., Tainer J.A. Mre11-Rad50-Nbs1 conformations and the control of sensing, signaling, and effector responses at DNA double-strand breaks. DNA Repair (Amst) 2010, 9:1299-1306.
113. Hohl M., Kwon Y., Galván S.M., Xue X., Tous C., Aguilera A., Sung P., Petrini J.H. The Rad50 coiled-coil domain is indispensable for Mre11 complex functions. Nat. Struct. Mol. Biol. 2011, 18:1124-1131.
114. Adelman C.A., De S., Petrini J.H. Rad50 is dispensable for the maintenance and viability of postmitotic tissues. Mol. Cell Biol. 2009, 29:483-492.
115. Kajiwara K., Berson E.L., Dryja T.P. Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROM1 loci. Science 1994, 264:1604-1608.
116. Fauser S., Munz M., Besch D. Further support for digenic inheritance in Bardet-Biedl syndrome. J. Med. Genet. 2003, 40:e104.
117. Thiel C., Kessler K., Giessl A., Dimmler A., Shalev S.A., von der Haar S., Zenker M., Zahnleiter D., Stöss H., Beinder E., Abou Jamra R., Ekici A.B., Schröder-Kress N., Aigner T., Kirchner T., Reis A., Brandstätter J.H., Rauch A. NEK1 mutations cause short-rib polydactyly syndrome type majewski. Am. J. Hum. Genet. 2011, 88:106-114.
118. El Hokayem J., Huber C., Couvé A., Aziza J., Baujat G., Bouvier R., Cavalcanti D.P., Collins F.A., Cordier M.P., Delezoide A.L., Gonzales M., Johnson D., Le Merrer M., Levy-Mozziconacci A., Loget P., Martin-Coignard D., Martinovic J., Mortier G.R., Perez M.J., Roume J., Scarano G., Munnich A., Cormier-Daire V. NEK1 and DYNC2H1 are both involved in short rib polydactyly Majewski type but not in Beemer Langer cases. J. Med. Genet. 2012, 49:227-233.
119. O'Driscoll M., Cerosaletti K.M., Girard P.M., Dai Y., Stumm M., Kysela B., Hirsch B., Gennery A., Palmer S.E., Seidel J., Gatti R.A., Varon R., Oettinger M.A., Neitzel H., Jeggo P.A., Concannon P. DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol. Cell. 2001, 8:1175-1185.
120. Buck D., Moshous D., de Chasseval R., Ma Y., le Deist F., Cavazzana-Calvo M., Fischer A., Casanova J.L., Lieber M.R., de Villartay J.P. Severe combined immunodeficiency and microcephaly in siblings with hypomorphic mutations in DNA ligase IV. Eur. J. Immunol. 2006, 36:224-235.
121. Frank K.M., Sharpless N.E., Gao Y., Sekiguchi J.M., Ferguson D.O., Zhu C., Manis J.P., Horner J., DePinho R.A., Alt F.W. DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway. Mol. Cell. 2000, 5:993-1002.
122. Orii K.E., Lee Y., Kondo N., McKinnon P.J. Selective utilization of nonhomologous end-joining and homologous recombination DNA repair pathways during nervous system development. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:10017-10022.
123. Gatz S.A., Ju L., Gruber R., Hoffmann E., Carr A.M., Wang Z.Q., Liu C., Jeggo P.A. Requirement for DNA ligase IV during embryonic neuronal development. J. Neurosci. 2011, 31:10088-10100.
124. Buck D., Malivert L., de Chasseval R., Barraud A., Fondanèche M.C., Sanal O., Plebani A., Stéphan J.L., Hufnagel M., le Deist F., Fischer A., Durandy A., de Villartay J.P., Cernunnos Revy P. a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell 2006, 124:287-299.
125. Dutrannoy V., Demuth I., Baumann U., Schindler D., Konrat K., Neitzel H., Gillessen-Kaesbach G., Radszewski J., Rothe S., Schellenberger M.T., Nürnberg G., Nürnberg P., Teik K.W., Nallusamy R., Reis A., Sperling K., Digweed M., Varon R. Clinical variability and novel mutations in the NHEJ1 gene in patients with a Nijmegen breakage syndrome-like phenotype. Hum. Mutat. 2010, 31:1059-1068.
126. Alter B.P., Rosenberg P.S., Brody L.C. Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2. J. Med. Genet. 2007, 44:1-9.
127. Reid S., Schindler D., Hanenberg H., Barker K., Hanks S., Kalb R., Neveling K., Kelly P., Seal S., Freund M., Wurm M., Batish S.D., Lach F.P., Yetgin S., Neitzel H., Ariffin H., Tischkowitz M., Mathew C.G., Auerbach A.D., Rahman N. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat. Genet. 2007, 39:162-164.
128. Xia B., Dorsman J.C., Ameziane N., de Vries Y., Rooimans M.A., Sheng Q., Pals G., Errami A., Gluckman E., Llera J., Wang W., Livingston D.M., Joenje H., de Winter J.P. Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat. Genet. 2007, 39:159-161.
129. Guo Z., Kozlov S., Lavin M.F., Person M.D., Paull T.T. ATM activation by oxidative stress. Science 2010, 330:517-521.
130. Stewart G.S., Stankovic T., Byrd P.J., Wechsler T., Miller E.S., Huissoon A., Drayson M.T., West S.C., Elledge S.J., Taylor A.M. RIDDLE immunodeficiency syndrome is linked to defects in 53BP1-mediated DNA damage signaling. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:16910-16915.
131. Stewart G.S., Panier S., Townsend K., Al-Hakim A.K., Kolas N.K., Miller E.S., Nakada S., Ylanko J., Olivarius S., Mendez M., Oldreive C., Wildenhain J., Tagliaferro A., Pelletier L., Taubenheim N., Durandy A., Byrd P.J., Stankovic T., Taylor A.M., Durocher D. The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling cascade at sites of DNA damage. Cell 2009, 136:420-434.
132. Devgan S.S., Sanal O., Doil C., Nakamura K., Nahas S.A., Pettijohn K., Bartek J., Lukas C., Lukas J., Gatti R.A. Homozygous deficiency of ubiquitin-ligase ring-finger protein RNF168 mimics the radiosensitivity syndrome of ataxia-telangiectasia. Cell Death Differ. 2011, 18:1500-1506.
133. Doil C., Mailand N., Bekker-Jensen S., Menard P., Larsen D.H., Pepperkok R., Ellenberg J., Panier S., Durocher D., Bartek J., Lukas J., Lukas C. RNF168 binds and amplifies ubiquitin conjugates on damaged chromosomes to allow accumulation of repair proteins. Cell 2009, 136:435-446.
134. Kuljis R.O., Chen G., Lee E.Y., Aguila M.C., Xu Y. ATM immunolocalization in mouse neuronal endosomes: implications for ataxia-telangiectasia. Brain Res. 1999, 842:351-358.
135. Watters D., Kedar P., Spring K., Bjorkman J., Chen P., Gatei M., Birrell G., Garrone B., Srinivasa P., Crane D.I., Lavin M.F. Localization of a portion of extranuclear ATM to peroxisomes. J. Biol. Chem. 1999, 274:34277-34282.
136. Li J., Han Y.R., Plummer M.R., Herrup K. Cytoplasmic ATM in neurons modulates synaptic function. Curr. Biol. 2009, 19:2091-2096.
137. Valentin-Vega Y.A., Maclean K.H., Tait-Mulder J., Milasta S., Steeves M., Dorsey F.C., Cleveland J.L., Green D.R., Kastan M.B. Mitochondrial dysfunction in ataxia-telangiectasia. Blood 2012, 119:1490-1500.